Laboratório de Imunopatologia, Instituto Butantan, São Paulo, Brazil.
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2442. doi: 10.1371/journal.pntd.0002442. eCollection 2013.
In Latin America, Bothrops snakes account for most snake bites in humans, and the recommended treatment is administration of multispecific Bothrops antivenom (SAB--soro antibotrópico). However, Bothrops snakes are very diverse with regard to their venom composition, which raises the issue of which venoms should be used as immunizing antigens for the production of pan-specific Bothrops antivenoms. In this study, we simultaneously compared the composition and reactivity with SAB of venoms collected from six species of snakes, distributed in pairs from three distinct phylogenetic clades: Bothrops, Bothropoides and Rhinocerophis. We also evaluated the neutralization of Bothrops atrox venom, which is the species responsible for most snake bites in the Amazon region, but not included in the immunization antigen mixture used to produce SAB. Using mass spectrometric and chromatographic approaches, we observed a lack of similarity in protein composition between the venoms from closely related snakes and a high similarity between the venoms of phylogenetically more distant snakes, suggesting little connection between taxonomic position and venom composition. P-III snake venom metalloproteinases (SVMPs) are the most antigenic toxins in the venoms of snakes from the Bothrops complex, whereas class P-I SVMPs, snake venom serine proteinases and phospholipases A2 reacted with antibodies in lower levels. Low molecular size toxins, such as disintegrins and bradykinin-potentiating peptides, were poorly antigenic. Toxins from the same protein family showed antigenic cross-reactivity among venoms from different species; SAB was efficient in neutralizing the B. atrox venom major toxins. Thus, we suggest that it is possible to obtain pan-specific effective antivenoms for Bothrops envenomations through immunization with venoms from only a few species of snakes, if these venoms contain protein classes that are representative of all species to which the antivenom is targeted.
在拉丁美洲,矛头蝮蛇导致了大多数人类被蛇咬伤的案例,推荐的治疗方法是注射多价矛头蝮蛇毒血清(SAB-多价抗蛇毒血清)。然而,矛头蝮蛇的毒液组成非常多样化,这就提出了一个问题,即应该使用哪些毒液作为免疫原来生产针对所有矛头蝮蛇的通用抗蛇毒血清。在这项研究中,我们同时比较了来自六个蛇种的毒液的组成和与 SAB 的反应性,这些蛇种分布在三个不同的进化枝中:矛头蝮属、矛头蝮属和棘鼻蛇属。我们还评估了对 SAB 免疫原混合物中未包含的造成亚马逊地区大多数蛇咬伤的物种——矛头蝮蛇的 B.atrox 毒液的中和作用。使用质谱和色谱方法,我们观察到亲缘关系密切的蛇的毒液在蛋白质组成上缺乏相似性,而进化上更远的蛇的毒液则具有高度相似性,这表明分类地位与毒液组成之间几乎没有联系。P-III 型蛇毒金属蛋白酶(SVMPs)是来自 Bothrops 复合物的蛇毒液中最具抗原性的毒素,而 P-I 型 SVMPs、蛇毒丝氨酸蛋白酶和磷脂酶 A2 与抗体的反应性较低。小分子量毒素,如 disintegrins 和 bradykinin-potentiating peptides,抗原性较差。来自同一蛋白家族的毒素在不同种蛇的毒液中表现出抗原交叉反应性;SAB 能够有效地中和 B.atrox 毒液的主要毒素。因此,我们认为,如果免疫原中包含针对目标所有物种具有代表性的蛋白类,那么仅使用少数几种蛇的毒液就有可能获得针对所有矛头蝮蛇的通用有效抗蛇毒血清。